Miller Anestesia

diagnostic block warranted? Anaesth Intensive Care

30:442-448, 2002.

153. Yan BM, Myers RP: Neurolytic celiac plexus block

for pain control in unresectable pancreatic cancer.

Am J Gastroenterol 102:430-438, 2007.

154. Slatkin NE, Rhiner M: Phenol saddle blocks for

intractable pain at end of life: Report of four cases

and literature review. Am J Hosp Palliat Care 20:62-

66, 2003.

155. El-Sayed GG: A new catheter technique for thoracic

subarachnoid neurolysis in advanced lung cancer

patients. Pain Pract 7:27-30, 2007.

156. Candido K, Stevens RA: Intrathecal neurolytic

blocks for the relief of cancer pain. Best Pract Res

Clin Anaesthesiol 17:407-428, 2003.

157. Boswell MV, Trescot AM, Datta S, et al: Interventio-

nal techniques: Evidence-based practice guidelines

in the management of chronic spinal pain. Pain

Physician 10:7-111, 2007.

158. Rosenow DE: Does neural blockade and other neu-

rosurgical modalities offer a durable pain relief for

spinal disorders? Best Pract Res Clin Rheumatol

16:155-164, 2002.

159. Pulisetti D, Ebraheim NA: CT-guided sacroiliac

joint injections. J Spinal Disord 12:310-312, 1999.

160. Shen FH, Samartzis D, Andersson GB: Nonsurgical

management of acute and chronic low back pain. J

Am Acad Orthop Surg 14:477-487, 2006.

161. Ashkenazi A, Levin M: Greater occipital nerve

block for migraine and other headaches: Is it useful?

Curr Pain Headache Rep 11:231-235, 2007.

162. Halbert J, Crotty M, Cameron ID: Evidence for the

optimal management of acute and chronic phantom

pain: A systematic review. Clin J Pain 18:84-92,

2002.

163. Kumar V, Krone K, Mathieu A: Neuraxial and sym-

pathetic blocks in herpes zoster and postherpetic

neuralgia: An appraisal of current evidence. Reg

Anesth Pain Med 29:454-461, 2004.

164. OpsteltenW, vanWijck AJ, Stolker RJ: Interventions

to prevent postherpetic neuralgia: Cutaneous and

percutaneous techniques. Pain 107:202-206, 2004.

165. Cepeda MS, Lau J, Carr DB: Defining the thera-

peutic role of local anesthetic sympathetic blockade

in complex regional pain syndrome: A narrative

and systematic review. Clin J Pain 18:216-233,

2002.

166. Varrassi G, Paladini A, Marinangeli F, Racz G:

Neural modulation by blocks and infusions. Pain

Pract 6:34-38, 2006.

167. Rho RH, Brewer RP, Lamer TJ, Wilson PR: Complex

regional pain syndrome. Mayo Clin Proc 77:174-

180, 2002.

168. Hassenbusch SJ, Portenoy RK, Cousins M, et al: Pol-

yanalgesic Consensus Conference 2003: An update

on the management of pain by intraspinal drug

delivery—report of an expert panel. J Pain Symptom

Manage 27:540-563, 2004.

169. Turner JA, Sears JM, Loeser JD: Programmable

intrathecal opioid delivery systems for chronic non-

cancer pain: A systematic review of effectiveness

and complications. Clin J Pain 23:180-195, 2007.

170. Diener HC, Kronfeld K, Boewing G, et al: Efficacy

of acupuncture for the prophylaxis of migraine: A

multicentre randomised controlled clinical trial.

Lancet Neurol 5:310-316, 2006.

171. Scharf HP, Mansmann U, Streitberger K, et al: Acu-

puncture and knee osteoarthritis: A three-armed

randomized trial. Ann Intern Med 145:12-20,

2006.

172. Kwon YD, Pittler MH, Ernst E: Acupuncture for

peripheral joint osteoarthritis: A systematic review

and meta-analysis. Rheumatology (Oxford)

45:1331-1337, 2006.

173. Casimiro L, Barnsley L, Brosseau L, et al: Acu-

puncture and electroacupuncture for the treatment

of rheumatoid arthritis. Cochrane Database Syst

Rev 3:CD003788, 2005.

174. Manheimer E, White A, Berman B, et al: Meta-

analysis: Acupuncture for low back pain. Ann Intern

Med 142:651-663, 2005.

175. Furlan AD, von Tulder M, Cherkin D, et al: Acu-

puncture and dry-needling for low back pain: An

updated systematic review within the framework of

the Cochrane collaboration. Spine 30:944-963,

2005.

176. van Tulder MW, Furlan AD, Gagnier JJ: Comple-

mentary and alternative therapies for low back pain.

Best Pract Res Clin Rheumatol 19:639-654, 2005.

177. Lee H, Schmidt K, Ernst E: Acupuncture for the

relief of cancer-related pain—a systematic review.

Eur J Pain 9:437-444, 2005.

178. Coffey RJ, Lozano AM: Neurostimulation for

chronic noncancer pain: An evaluation of the clini-

cal evidence and recommendations for future trial

designs. J Neurosurg 105:175-189, 2006.

179. Cruccu G, Aziz TZ, Garcia-Larrea L, et al: EFNS

guidelines on neurostimulation therapy for neuro-

pathic pain. Eur J Neurol 14:952-970, 2007.

180. Taylor RS: Spinal cord stimulation in complex

regional pain syndrome and refractory neuropathic

back and leg pain/failed back surgery syndrome:

Results of a systematic review and meta-analysis. J

Pain Symptom Manage 31:S13-S19, 2006.

181. Khadilkar A, Milne S, Brosseau L, et al: Transcuta-

neous electrical nerve stimulation for the treatment

of chronic low back pain: A systematic review. Spine

30:2657-2666, 2005.

182. Osiri M, Welch V, Brosseau L, et al: Transcutaneous

electrical nerve stimulation for knee osteoarthritis.

Cochrane Database Syst Rev 4:CD002823, 2000.

183. Brosseau L, Judd MG, Marchand S, et al: Transcuta-

neous electrical nerve stimulation (TENS) for the

treatment of rheumatoid arthritis in the hand.

Cochrane Database Syst Rev 3:CD004377, 2003.

184. Magnani B, Johnson LR, Ferrante FM: Modifiers of

patient-controlled analgesia efficacy. II. Chronic

pain. Pain 39:23-29, 1989.

185. Slappendel R, Weber EW, Bugter ML, Dirksen R:

The intensity of preoperative pain is directly corre-

lated with the amount of morphine needed for

postoperative analgesia. Anesth Analg 88:146-148,

1999.

186. Thielking PD: Cancer pain and anxiety. Curr Pain

Headache Rep 7:249-261, 2003.

187. Bigal ME, Rapoport AM, Sheftell FD, et al: Trans-

formed migraine and medication overuse in a ter-

tiary headache centre—clinical characteristics and

treatment outcomes. Cephalalgia 24:483-490, 2004.

188. Ready LB, Sarkis E, Turner JA: Self-reported vs.

actual use of medications in chronic pain patients.

Pain 12:285-294, 1982.

189. Hadi I, Morley-Forster PK, Dain S, et al: Brief

review: Perioperative management of the patient

with chronic non-cancer pain. [Article de synthese

court: Prise en charge perioperatoire des patients

souffrant de douleur chronique non cancereuse.].

Can J Anaesth 53:1190-1199, 2006.

190. de Leon-Casasola OA, Myers DP, Donaparthi

S, et al: A comparison of postoperative epidu-

ral analgesia between patients with chronic

cancer taking high doses of oral opioids versus

opioid-naive patients. Anesth Analg 76:302-

307, 1993.

191. Elliott AM, Smith BH, Penny KI, et al: The epide-

miology of chronic pain in the community. Lancet

354:1248-1252, 1999.

192. Broadman LM: Non-steroidal anti-inflammatory

drugs,antiplateletmedicationsandspinalaxisanesthe-

sia. Best Pract Res Clin Anaesthesiol 19:47-58, 2005.

193. Fassoulaki A, Patris K, Sarantopoulos C, Hogan Q:

The analgesic effect of gabapentin and mexiletine

after breast surgery for cancer. Anesth Analg 95:985-

991, 2002.

194. Alloul K, Whalley DG, Shutway F, et al: Pharmaco-

kinetic origin of carbamazepine-induced resistance

to vecuronium neuromuscular blockade in anesthe-

tized patients. Anesthesiology 84:330-339, 1996.

195. Stillman MJ, Zajac D, Rybicki LA: Treatment of

primary headache disorders with intravenous val-

proate: Initial outpatient experience. Headache

44:65-69, 2004.

196. Pohlmann-Eden B, Peters CN, Wennberg R,

Dempfle CE: Valproate induces reversible factor

XIII deficiency with risk of perioperative bleeding.

Acta Neurol Scand 108:142-145, 2003.

197. Kudoh A, Katagai H, Takazawa T: Antidepressant

treatment for chronic depressed patients should not

be discontinued prior to anesthesia. Can J Anaesth

49:132-136, 2002.

198. Sarton E, Teppema LJ, Olievier C, et al: The invol-

vement of the mu-opioid receptor in ketamine-

inducedrespiratorydepressionandantinociception.

Anesth Analg 93:1495-1500, 2001.

199. Visser E, Schug SA: The role of ketamine in pain

management. Biomed Pharmacother 60:341-348,

2006.

200. Benitez-Rosario MA, Feria M, Salinas-Martin A, et

al: A retrospective comparison of the dose ratio

between subcutaneous and oral ketamine. J Pain

Symptom Manage 25:400-402, 2003.

201. Pal HR, Berry N, Kumar R, Ray R: Ketamine depen-

dence. Anaesth Intensive Care 30:382-384, 2002.

202.

PassikSD,LundbergJ,KirshKL

,etal:Apilotexplo-

ration of the antiemetic activity of olanzapine for the

relief of nausea in patients with advanced cancer and

pain. J Pain Symptom Manage 23:526-532, 2002.

203. Simon GE, VonKorff M, Barlow W, et al: Predictors

of chronic benzodiazepine use in a health mainte-

nance organization sample. J Clin Epidemiol

49:1067-1073, 1996.

204. Savage SR, Joranson DE, Covington EC, et al: Defi-

nitions related to the medical use of opioids: Evolu-

tion towards universal agreement. J Pain Symptom

Manage 26:655-667, 2003.

205. June HL, Stitzer ML, Cone E: Acute physical depen-

dence: Time course and relation to human plasma

morphine concentrations. Clin Pharmacol Ther

57:270-280, 1995.

206. Compton P, Miotto K, Elashoff D: Precipitated

opioid withdrawal across acute physical depen-

dence induction methods. Pharmacol Biochem

Behav 77:263-268, 2004.

207. Ketter TA, Malow BA, Flamini R, et al: Anticonvul-

sant withdrawal—emergent psychopathology. Neu-

rology 44:55-61, 1994.

208. Peng PW, Tumber PS, Gourlay D: Review article:

Perioperative pain management of patients on

methadone therapy. Can J Anaesth 52:513-523, 2005.

209. Laffey JG, Coleman M, Boylan JF: Patients’

knowledge of perioperative care. Ir J Med Sci

169:113-118, 2000.

210. Practice guidelines for postanesthetic care: A report

by the American Society of Anesthesiologists Task

Force on Postanesthetic Care. Anesthesiology

96:742-752, 2002.

Anestesia y tratamiento del dolor crónico

1583

Seccíon IV

Anestesia por subespecialidades en el adulto